Alterations of the genes involved in the PI3K and estrogen-receptor pathways influence outcome in human epidermal growth factor receptor 2-positive and hormone receptor-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy

Peer Review reports

Original Submission
11 Feb 2013	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
13 May 2013	Author responded	Author comments - Yasuhiko Kaneko
Resubmission - Version 3
13 May 2013	Submitted	Manuscript version 3
Publishing
13 May 2013	Editorially accepted
16 May 2013	Article published	10.1186/1471-2407-13-241

Back to article page